share_log

Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $18.61

Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $18.61

Truist證券維持對cross country healthcare的持有評級,將目標價格提高到$18.61
Benzinga ·  2024/12/06 00:46  · 評級/大行評級

Truist Securities analyst Tobey Sommer maintains Cross Country Healthcare (NASDAQ:CCRN) with a Hold and raises the price target from $15 to $18.61.

Truist Securities分析師託比·索默維持Cross Country Healthcare(納斯達克股票代碼:CCRN)的持倉並將目標股價從15美元上調至18.61美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論